GURU.Markets stock price, segment price, and overall market index valuation
The company's share price OraSure Technologies
OraSure Technologies produces diagnostic tests, including rapid tests for HIV and COVID-19. Its share price reflects the demand for rapid diagnostics, which has surged during the pandemic, but also the intense competition in this sector.
Share prices of companies in the market segment - Medanalysis
OraSure Technologies (OSUR) develops and manufactures systems for collecting saliva and other biological fluids, as well as rapid diagnostic tests for infectious diseases, including HIV. We classify it as a "Medanalysis" company. The chart below shows the overall dynamics of the diagnostic testing sector.
Broad Market Index - GURU.Markets
OraSure Technologies develops and markets saliva-based diagnostic tests for various diseases. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how OraSure compares to it.
Change in the price of a company, segment, and market as a whole per day
OSUR - Daily change in the company's share price OraSure Technologies
The daily price change of OraSure, a diagnostic test manufacturer, reflects demand for its products, including COVID-19 tests. Change_co measures volatility related to the epidemiological situation and competition. This metric is important for analyzing companies in the diagnostics sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medanalysis
OraSure Technologies, Inc. is a medical diagnostics company. This chart shows the average daily volatility of the sector. Comparing it to OSUR's performance, with its HIV and COVID-19 tests, helps assess its sensitivity to demand for diagnostic solutions.
Daily change in the price of a broad market stock, index - GURU.Markets
OraSure is a manufacturer of diagnostic tests for the rapid detection of infectious diseases. The medical diagnostics sector is sensitive to pandemics and innovation. The chart below shows the volatility in this niche, allowing you to compare OraSure's performance with other companies.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization OraSure Technologies
OraSure Technologies' year-over-year performance tells a story about the demand for its diagnostic tests. Its market capitalization change over the past 12 months reflects both sales of its COVID-19 and HIV tests and the success of its subsidiary, DNA Genotek, a leader in collecting DNA samples for genetic research, making it a diversified player in the diagnostics space.
Annual dynamics of market capitalization of the market segment - Medanalysis
OraSure Technologies, Inc., a leader in saliva-based diagnostics, is adapting to the decline in demand for COVID-19 tests. This chart will show how successful its efforts to grow its core business are and how it competes in the diagnostic testing market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
OraSure, a diagnostic testing company, is experiencing a post-pandemic recovery. Its stock price reflects the decline in demand for COVID-19 tests and a return to business as usual, more stable. This chart tells the story of how the company is adapting to life after an unprecedented boom.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization OraSure Technologies
OraSure, a diagnostic testing maker, is driven by its product cycle. The monthly fluctuations in the chart reflect the sharply reduced demand for its COVID-19 tests and its ability to grow sales in other segments, such as HIV diagnostics and DNA sampling.
Monthly dynamics of market capitalization of the market segment - Medanalysis
OraSure Technologies develops and manufactures rapid diagnostic tests using saliva samples, including for HIV and COVID-19. The company simplifies testing, making it accessible outside of laboratories. The chart below reflects the overall sentiment in the medical analytics and diagnostics sector.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
OraSure Technologies produces diagnostic tests, including COVID-19 and HIV tests. Demand for its products can be event-driven, rising sharply during epidemics. This makes its shares volatile and subject to market movements based on healthcare news.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization OraSure Technologies
OraSure Technologies, a manufacturer of diagnostic tests, including for COVID-19 and HIV, reacts to healthcare news. Weekly price movements depend on demand for its tests, pandemic news, and the competitive environment. The chart below shows how short-term public health events affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Is OraSure Technologies moving in sync with the diagnostics sector? The chart below compares the weekly performance of this testing maker's shares with the industry average. This allows us to see whether its reaction to public health news (such as pandemics) is more pronounced than that of other diagnostics companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
OraSure Technologies produces diagnostic tests, including rapid COVID-19 and HIV tests. This chart compares its weekly performance to the market. It helps understand how its stock is affected by news about pandemics and government procurement of tests, often causing it to move independently of the market.
Market capitalization of the company, segment and market as a whole
OSUR - Market capitalization of the company OraSure Technologies
The chart below shows OraSure Technologies' valuation, reflecting its position in the rapid diagnostics market, including HIV and COVID-19 tests. The company's market capitalization depends on demand for its diagnostic products and innovations in sample collection. The dynamics illustrate how its value can fluctuate dramatically depending on the epidemiological situation.
OSUR - Share of the company's market capitalization OraSure Technologies within the market segment - Medanalysis
OraSure Technologies, Inc. holds a significant market share in rapid saliva diagnostic tests. Its market capitalization reflects its leadership in HIV testing and its expansion into COVID-19 diagnostics and DNA sampling.
Market capitalization of the market segment - Medanalysis
This chart shows the total market capitalization of point-of-care diagnostic test manufacturers. OraSure Technologies, with its saliva tests, is the leader in this niche. The dynamics in the chart reflect the growing demand for rapid and non-invasive diagnostics.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows the market value of rapid and affordable diagnostics. The market capitalization of OraSure Technologies, known for its rapid HIV and COVID-19 tests, reflects the global demand for self-testing. The line shows the importance of technologies that give people control over their health.
Book value capitalization of the company, segment and market as a whole
OSUR - Book value capitalization of the company OraSure Technologies
This chart shows the value of OraSure Technologies' physical and intellectual assets. The line represents its estimated production capacity for diagnostic tests (including COVID-19 and HIV tests) and sample collection devices. The trend reflects investments in expanding the diagnostic portfolio.
OSUR - Share of the company's book capitalization OraSure Technologies within the market segment - Medanalysis
OraSure's tangible assets include its US production lines, where diagnostic tests are manufactured, including those for HIV and COVID-19 antibodies. The chart shows the company's share of this critical public health production infrastructure, which enables mass testing.
Market segment balance sheet capitalization - Medanalysis
Below you can see the overall book value of the medical equipment sector. Against this backdrop, OraSure, as a diagnostic test manufacturer, is moderately capital-intensive. Test development and production require the ownership of certified production lines, which contributes to its net worth.
Book value of all companies included in the broad market index - GURU.Markets
OraSure Technologies manufactures and markets diagnostic tests, including those for saliva sampling. The company's assets include manufacturing facilities and R&D laboratories. The balance of these assets is the value of the technology that makes medical diagnostics simple and accessible, changing the physical reality of sample collection.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - OraSure Technologies
OraSure's balance sheet consists of its diagnostic test manufacturing facilities. Market valuation, when below book value, reflects declining demand for COVID-19 tests and doubts about future growth sources. The MvsBCap_Co < 1 chart here is a story of how yesterday's hero became today's underdog.
Market to book capitalization ratio in a market segment - Medanalysis
OraSure Technologies produces rapid diagnostic tests, including HIV and COVID-19 tests. The chart shows how the market evaluates its product portfolio and its ability to develop and commercialize new diagnostic solutions to address healthcare needs.
Market to book capitalization ratio for the market as a whole
OraSure Technologies develops and manufactures diagnostic tests for saliva samples, as well as infectious disease tests. The company is a pioneer in non-invasive diagnostics. This chart illustrates why research-intensive companies in the medical diagnostics sector can command a premium to their tangible assets.
Debts of the company, segment and market as a whole
OSUR - Company debts OraSure Technologies
OraSure Technologies, a diagnostic testing manufacturer, has adopted a debt policy that reflects its adaptation to market changes. This chart shows how the company is managing capital following the decline in demand for COVID-19 tests, investing in other areas, such as HIV testing and DNA sampling. Debt is used as a tool for diversification and finding new growth opportunities.
Market segment debts - Medanalysis
OraSure Technologies produces saliva-based diagnostic tests, including tests for HIV and COVID-19. Developing and producing medical tests requires investment in R&D and manufacturing capacity. This chart shows how the company manages its capital to bring new diagnostic solutions to market and compete in this space.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio OraSure Technologies
OraSure Technologies manufactures and markets diagnostic tests, including COVID-19 and HIV tests. This chart shows the company's financial structure. In the rapidly changing medical diagnostics sector, where demand for certain tests can rise and fall sharply, a moderate debt load gives the company greater flexibility to adapt to new market conditions.
Market segment debt to market segment book capitalization - Medanalysis
OraSure Technologies produces saliva-based diagnostic tests, including those for HIV and COVID-19. Developing and commercializing new diagnostic systems requires investment. The chart below shows how the company's debt burden compares to overall market capitalization and financial standards in the medical diagnostics sector.
Debt to book value of all companies in the market
#VALUE!
P/E of the company, segment and market as a whole
P/E - OraSure Technologies
This chart shows the valuation of OraSure Technologies, a manufacturer of diagnostic tests, including HIV and COVID-19 tests. The company's P/E can be highly volatile. It rose sharply during the pandemic and then declined as demand for COVID tests declined. The valuation now depends on its ability to grow other business lines.
P/E of the market segment - Medanalysis
This chart shows the average P/E valuation for diagnostic test manufacturers. For OraSure Technologies, this is an important barometer. Comparing its P/E to the industry average helps understand how investors view its product portfolio post-pandemic and its ability to generate stable growth in a more predictable environment.
P/E of the market as a whole
OraSure Technologies develops and manufactures saliva collection systems and rapid diagnostic tests for infectious diseases, including HIV and COVID-19. The company's products make testing simpler and more accessible. This chart, reflecting overall sentiment, helps understand how investors view the medical diagnostics sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company OraSure Technologies
OraSure Technologies develops and manufactures diagnostic tests and sample collection tools, including saliva tests for HIV and COVID-19. This graph shows expectations for the future of diagnostics. These expectations are based on demand for its tests, the success of new product launches, and competition in the rapidly evolving field of medical testing.
%20P%2FE%20OraSure%20Technologies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-OraSure-Technologies&v=1772615912039 "Chart of the company's future (projected) P/E OraSure Technologies")
Future (projected) P/E of the market segment - Medanalysis
OraSure Technologies produces rapid diagnostic tests, including saliva tests for HIV and COVID-19. This chart compares the company's future profitability expectations with industry forecasts. It reflects how the market assesses their ability to develop and commercialize new, in-demand diagnostic products.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772615912054 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
OraSure Technologies produces diagnostic tests, including saliva-based HIV and COVID-19 tests. Demand for its products depends on the epidemiological situation and public health programs. This overall market outlook is less important to OraSure than government procurement and emerging viral threats.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772615912076 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit OraSure Technologies
OraSure Technologies manufactures and markets rapid diagnostic tests, including saliva-based HIV and COVID-19 tests, as well as DNA collection kits. The company's revenue depends on demand for rapid, non-invasive diagnostics from consumers and healthcare systems.
Profit of companies in the market segment - Medanalysis
OraSure Technologies produces diagnostic tests, including rapid tests for HIV and COVID-19. The company's profitability depends on demand for rapid diagnostics and government programs. This chart shows how the medical diagnostics sector is responding to the epidemiological situation and technological innovations that shape its financial results.
Overall market profit
OraSure Technologies produces diagnostic tests for the rapid detection of diseases, including HIV and hepatitis C, as well as drug screening tests. Demand for its products is driven by public health programs and corporate testing rather than general economic cycles. This makes its business relatively stable and non-cyclical.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company OraSure Technologies
OraSure Technologies produces point-of-care diagnostic tests, including HIV and COVID-19 tests. This chart shows revenue expectations, which are based on sales volumes of its diagnostic kits. Demand from government healthcare programs and private employers shapes these forecasts.
%20profit%20of%20the%20company%20OraSure%20Technologies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-OraSure-Technologies&v=1772615912188 "Graph of future (projected) profit of the company OraSure Technologies")
Future (predicted) profit of companies in the market segment - Medanalysis
OraSure Technologies manufactures and markets point-of-care and at-home diagnostic tests, including HIV and COVID-19 tests. This chart shows revenue forecasts for the entire medical diagnostics sector. It reflects expected demand for rapid and convenient testing methods. This trend is important for evaluating OraSure's product portfolio and future developments.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772615912195 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
OraSure Technologies produces rapid saliva-based diagnostic tests, including HIV and COVID-19 tests. Demand for its products depends on public health programs and consumer demand. The economic forecasts presented here may impact government healthcare budgets and the public's willingness to spend money on self-testing.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772615912213 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - OraSure Technologies
OraSure Technologies manufactures and sells rapid diagnostic tests, including saliva tests for HIV and COVID-19, as well as DNA collection kits. This chart shows how investors estimate its revenue, which can be volatile depending on demand for infectious disease tests and the growth of the genetic testing market.
P/S market segment - Medanalysis
OraSure Technologies develops and manufactures saliva collection systems and rapid diagnostic tests for infectious diseases such as HIV and hepatitis C, as well as COVID-19 tests. This chart shows the average market value for OraSure's diagnostic technologies and product portfolio, helping to understand how the market compares to its competitors.
P/S of the market as a whole
OraSure Technologies develops and manufactures diagnostic tests and sample collection tools, including saliva-based HIV and COVID-19 detection. This makes testing more accessible and convenient. This market valuation chart compares how investors value the medical diagnostics sector's revenue compared to other industries.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company OraSure Technologies
OraSure Technologies produces diagnostic tests, including those for HIV and COVID-19 detection using saliva. Future revenue depends on demand for its tests and the successful launch of new products. This chart shows the market's perception of its diagnostic portfolio and growth potential in molecular diagnostics.
%20P%2FS%20OraSure%20Technologies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-OraSure-Technologies&v=1772615912303 "The graph of the company's future (projected) P/S OraSure Technologies")
Future (projected) P/S of the market segment - Medanalysis
OraSure Technologies develops and markets diagnostic tests for saliva samples and molecular diagnostics. This chart compares the company's future sales estimates with those of other analyst firms. It shows how investors view its product portfolio, including COVID-19 and HIV tests, and its innovative platforms.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772615912323 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
OraSure Technologies produces diagnostic tests, including those for HIV and COVID-19. Demand for its products depends on healthcare needs. General economic optimism, reflected in this chart, influences government funding for testing programs and people's willingness to spend money on diagnostics to maintain their health.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772615912343 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales OraSure Technologies
OraSure Technologies develops and markets diagnostic tests and sample collection tools, including saliva tests for HIV and COVID-19. The company's revenue comes from sales of these easy-to-use diagnostic products. The chart shows demand for its point-of-care and self-administered testing solutions.
Sales of companies in the market segment - Medanalysis
OraSure Technologies develops and manufactures saliva collection systems and rapid diagnostic tests for infectious diseases, including HIV and COVID-19. The company's revenue is generated from sales of these diagnostic products. This chart shows the state of the point-of-care diagnostics market, where demand for rapid and non-invasive tests is constantly growing, especially during pandemics.
Overall market sales
OraSure Technologies produces diagnostic tests, including those for HIV and COVID-19. Demand for its products depends on public health needs and government programs. While this business is less cyclical, the overall economic situation, as reflected here, influences government budgets allocated for disease screening and diagnostics.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company OraSure Technologies
OraSure Technologies produces point-of-care diagnostic tests, including rapid HIV and COVID-19 tests, as well as saliva collection kits. This chart shows analysts' expectations for diagnostic test demand after the pandemic and the success of the company's new products.
%20sales%20of%20the%20company%20OraSure%20Technologies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-OraSure-Technologies&v=1772615912471 "Schedule of future (projected) sales of the company OraSure Technologies")
Future (projected) sales of companies in the market segment - Medanalysis
OraSure Technologies develops and markets diagnostic tests and sample collection tools, including saliva tests for HIV and COVID-19. This chart illustrates expectations for the medical testing sector. It helps analyze how the company is adapting to reduced demand for COVID tests and developing other areas of its diagnostics business.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772615912482 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
OraSure Technologies produces diagnostic tests for the rapid detection of infectious diseases and genetic analysis. This graph, reflecting healthcare costs, is important to the company. Government screening programs and overall economic stability, allowing people to afford diagnostics, support demand for OraSure's products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772615912497 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality OraSure Technologies
OraSure Technologies develops and markets diagnostic tests and sample collection tools, including saliva tests for COVID-19 and HIV. The company's profitability depends on sales volume and manufacturing efficiency. This chart shows how the company is converting demand for fast and convenient diagnostics into financial returns for its shareholders.
Market segment marginality - Medanalysis
OraSure Technologies produces rapid diagnostic tests, including saliva-based HIV and COVID-19 tests. Their advantages include non-invasiveness and ease of use. This chart illustrates how their focus on point-of-care diagnostics and innovative products are driving operational efficiency in the medical testing sector.
Market marginality as a whole
OraSure Technologies produces rapid diagnostic tests, including HIV and COVID-19 tests. While their overall profitability has been positive, their business has experienced fluctuations in demand due to the pandemic. Their current profitability depends on their ability to find new markets for their diagnostic products and diversify their revenues.
Employees in the company, segment and market as a whole
Number of employees in the company OraSure Technologies
OraSure Technologies is a leader in sample collection and rapid diagnostics. This graph shows the team, which has grown significantly during the pandemic. The scale of its staff reflects its manufacturing capacity and ability to quickly respond to global public health needs.
Share of the company's employees OraSure Technologies within the market segment - Medanalysis
OraSure Technologies develops and manufactures diagnostic tests and sample collection tools, including saliva tests for COVID-19 and HIV. This chart shows the company's market share in the medical diagnostics sector. It reflects the scale of its manufacturing and research efforts, aimed at creating simple and affordable diagnostic tools.
Number of employees in the market segment - Medanalysis
OraSure Technologies produces point-of-care diagnostic tests, including rapid HIV and COVID-19 tests. This chart shows employment in the medical diagnostics sector. Fluctuations in staffing levels may reflect changes in test demand, as seen during the pandemic, highlighting the importance of rapid diagnostics.
Number of employees in the market as a whole
OraSure Technologies produces rapid diagnostic tests, including saliva tests for HIV and COVID-19, as well as DNA collection kits. It is a significant player in the public health sector. This chart reflects overall employment, and the medical diagnostics sector represented by OraSure is experiencing steady growth, driven by both pandemics and the advancement of personalized medicine.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company OraSure Technologies (OSUR)
OraSure Technologies, Inc. develops and markets diagnostic tests, including HIV and COVID-19 tests. Its business combines R&D and manufacturing. This chart shows that the capitalization per employee reflects both the value of intellectual property (test patents) and the efficiency of its production lines. This is a balanced model for a medical device company.
%20of%20the%20company%20OraSure%20Technologies%20(OSUR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-OraSure-Technologies-OSUR&v=1772615912602 "Chart of market capitalization per employee (in thousands of dollars) of the company OraSure Technologies (OSUR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
OraSure Technologies produces diagnostic solutions, including saliva tests for COVID-19 and HIV. In the medtech industry, both innovation and scale are important. This metric allows one to assess how effectively a company combines R&D and manufacturing capabilities to create value, which can be compared with other diagnostic companies.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772615912632 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
OraSure Technologies produces rapid diagnostic tests, including saliva-based HIV and COVID-19 tests. The company's value lies in its convenient and non-invasive technologies. This chart reflects how the market evaluates the company's ability to develop and commercialize rapid and affordable diagnostic solutions.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772615912650 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company OraSure Technologies (OSUR)
OraSure Technologies (OSUR) produces rapid diagnostic testing systems (including saliva tests for COVID-19 and HIV). It's a medical technology company. This chart shows how efficiently the company manages its production and R&D. It measures the profit each employee generates and can fluctuate greatly depending on demand for their tests (as was the case during the pandemic).
%20Chart%20OraSure%20Technologies%20(OSUR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-OraSure-Technologies-OSUR&v=1772615912742 "Company Profit Per Employee (in thousands of dollars) Chart OraSure Technologies (OSUR)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
OraSure Technologies produces saliva sample collection systems and rapid tests (HIV, COVID-19). Their business is non-invasive diagnostics. This chart shows an industry benchmark. It helps evaluate how effectively OraSure is monetizing its proprietary biospecimen collection technologies and diagnostic platforms.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772615912813 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
OraSure Technologies produces diagnostic tests, primarily using saliva-based sample collection technology (e.g., HIV, drug testing, and COVID-19). It is a manufacturing and sales business for medical supplies. Profit per employee here is a measure of their production efficiency (the cost of one test) and the success of their sales team in bringing these tests to market.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772615912899 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee OraSure Technologies (OSUR)
OraSure Technologies produces rapid diagnostic tests, including HIV and COVID-19 tests. This chart shows the dynamics of the medical technology sector. Revenue per employee can fluctuate significantly depending on the epidemiological situation and government procurement, which was particularly noticeable during the pandemic.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-OraSure-Technologies-OSUR&v=1772615912913 "Sales chart per company employee OraSure Technologies (OSUR)")
Sales per employee in the market segment - Medanalysis
OraSure Technologies (OSUR) is a company specializing in saliva collection technologies and rapid diagnostics (including COVID-19 and HIV tests). This chart shows how much revenue each employee generates from sales of their diagnostic products. It's an indicator of the effectiveness of their R&D and manufacturing model in the medical technology sector.
Sales per employee for the market as a whole
OraSure Technologies produces diagnostic tests, primarily for saliva-based (oral fluid) samples. They are known for their HIV tests and COVID-19 tests. They are a medical manufacturing company. This chart shows how efficiently the company produces and sells its diagnostic kits, which can fluctuate significantly depending on the epidemiological situation.
Short shares by company, segment and market as a whole
Shares shorted by company OraSure Technologies (OSUR)
OraSure Technologies is a manufacturer of diagnostic tests, including HIV and COVID-19 saliva tests, as well as DNA collection kits. This chart shows bearish bets. The shorts are driven by the sharp decline in COVID-19 test revenue since the pandemic ended. The company now needs to prove that its core business can grow.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-OraSure-Technologies-OSUR&v=1772615912990 "Short Shares Chart for the Company OraSure Technologies (OSUR)")
Shares shorted by market segment - Medanalysis
OraSure Technologies (OSUR) is a company specializing in saliva-based diagnostic tests, including tests for HIV, hepatitis C, and COVID-19. This chart shows bets against the medical diagnostics sector. The rising bets against the industry reflect investor concerns about a sharp decline in demand for COVID tests following the pandemic, which has devastated OraSure's revenue.
Shares shorted by the overall market
OraSure Technologies (OSUR) produces diagnostic tests (including for COVID-19 and HIV) and sample collection. This business can be both stable and volatile (as during a pandemic). This market fear chart shows investors seeking protection. OSUR's stable diagnostic business may be attractive, but a decline in demand for tests is not.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator OraSure Technologies (OSUR)
OraSure Technologies, known for its diagnostic tests (including COVID and HIV), sees stock price fluctuations based on healthcare news. This chart helps gauge sentiment. A rise above 70 may reflect peak demand for tests or optimism about new products, signaling overbought conditions. A rise below 30 may indicate panic due to declining demand, competition, or setbacks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-OraSure-Technologies-OSUR&v=1772615913025 "RSI 14 indicator chart for the company's stock OraSure Technologies (OSUR)")
RSI 14 Market Segment - Medanalysis
OraSure Technologies is a pioneer in non-invasive diagnostics, known for its saliva tests (including COVID-19) and genomic sample collection solutions (DNA Genotek). This chart measures the overall momentum across the medical diagnostics sector. It helps understand whether fluctuations in OSUR are driven by its own products or whether this is a general "overheating" or "slump" across the industry.
RSI 14 for the overall market
For OraSure, a diagnostic test maker (including COVID tests), this chart is a double-edged sword. During periods of market euphoria, its core business (HIV tests) is stable. However, market panic related to the threat of a pandemic could trigger an explosive increase in demand for its products, as has already happened, making it a unique asset during a crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast OSUR (OraSure Technologies)
OraSure Technologies produces diagnostic tests, including rapid HIV and HCV tests (saliva-based), as well as DNA collection kits (Genotek). This chart shows the average analyst forecast. Their targets are based on diagnostic kit sales and growing demand for molecular diagnostic tests.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-OSUR-OraSure-Technologies&v=1772615913083 "A chart showing analyst consensus forecasts for the expected stock price. OSUR (OraSure Technologies)")
The difference between the consensus estimate and the actual stock price OSUR (OraSure Technologies)
OraSure (OSUR) is a non-invasive diagnostics company producing saliva-based HIV and COVID tests, as well as DNA collection kits. This chart shows their reversal estimate. It measures the gap between the price and the consensus target, reflecting whether analysts believe they can recover from the COVID testing decline.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-OSUR-OraSure-Technologies&v=1772615913113 "A chart showing the difference between the consensus forecast and the actual stock price. OSUR (OraSure Technologies)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
OraSure Technologies (OSUR) is a leader in alternative diagnostics. The company produces tests (HIV, COVID-19) based on saliva and microbiome samples. This chart shows analysts' overall expectations for the medical testing sector. It reflects whether experts believe non-invasive diagnostics (without blood) will grow.
Analysts' consensus forecast for the overall market share price
OraSure Technologies produces saliva-based diagnostic tests for rapid HIV and hepatitis C testing, as well as COVID-19 tests. This chart shows overall market sentiment. For OraSure, which operates in the defensive diagnostics sector, overall optimism is important, but their business is also highly dependent on government healthcare programs and the epidemiological situation.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index OraSure Technologies
OraSure Technologies (OSUR) is a champion of noninvasive diagnostics. Their specialty is saliva-based tests (OraQuick) for HIV and hepatitis C, as well as DNA sample collection (Oragene). This chart is a summary indicator of their consumables. It reflects their stable sales in the DNA segment and volatile demand for their diagnostic tests (including COVID-19).
AKIMA Market Segment Index - Medanalysis
OraSure Technologies produces diagnostic tests, including rapid HIV and COVID-19 tests, as well as DNA collection kits. This chart shows the average index for the medical testing sector. It allows you to assess how OraSure, which operates in both the consumer and medical markets, performs compared to the average of its competitors.
The AKIM Index for the overall market
OraSure Technologies is a leader in rapid diagnostics (HIV, COVID, hepatitis C) and sample collection (saliva, microbiome). This chart, reflecting the market average, is a backdrop. It helps assess how this business, balancing pandemic demand with its core portfolio, fares against the backdrop of overall macroeconomic fluctuations.
